Lisdexamfetamine 30 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FJK1H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,266
Award facts
- Contract value 100% obligated
- $16,266.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,266.12 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (100-count units) on January 27, 2026, with an ultimate completion date of January 28, 2026. The contract utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen maintains a critical role in the federal pharmaceutical supply chain, particularly for Department of Defense and military healthcare systems. The company's extensive portfolio encompasses specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Lisdexamfetamine, a controlled substance medication used in treating attention deficit hyperactivity disorder, reflects the company's capability to fulfill federal requirements for prescription pharmaceuticals essential to military treatment facilities and veteran healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FJK1H?
SPE2DR26FJK1H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FJK1H worth?
The government has obligated $16,266 on SPE2DR26FJK1H.
Is contract SPE2DR26FJK1H an order under another contract?
Yes. SPE2DR26FJK1H is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJK1H competed?
The extent of competition for SPE2DR26FJK1H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award